Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
IFF vs SHW vs FMC vs AVNT vs BCPC
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Agricultural Inputs
Chemicals - Specialty
Chemicals - Specialty
IFF vs SHW vs FMC vs AVNT vs BCPC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Agricultural Inputs | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $19.99B | $78.98B | $1.71B | $3.35B | $5.11B |
| Revenue (TTM) | $10.79B | $23.94B | $3.43B | $3.28B | $1.06B |
| Net Income (TTM) | $839M | $2.60B | $-2.50B | $158M | $158M |
| Gross Margin | 35.1% | 49.1% | 35.3% | 31.7% | 36.3% |
| Operating Margin | 8.0% | 16.1% | -59.5% | 9.3% | 21.0% |
| Forward P/E | 17.8x | 27.3x | 7.7x | 12.0x | 30.9x |
| Total Debt | $6.65B | $14.53B | $4.20B | $1.92B | $192M |
| Cash & Equiv. | $590M | $207M | $585M | $511M | $75M |
IFF vs SHW vs FMC vs AVNT vs BCPC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| International Flavo… (IFF) | 100 | 58.8 | -41.2% |
| The Sherwin-William… (SHW) | 100 | 161.8 | +61.8% |
| FMC Corporation (FMC) | 100 | 13.9 | -86.1% |
| Avient Corporation (AVNT) | 100 | 147.3 | +47.3% |
| Balchem Corporation (BCPC) | 100 | 158.5 | +58.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IFF vs SHW vs FMC vs AVNT vs BCPC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IFF ranks third and is worth considering specifically for momentum.
- +8.5% vs FMC's -57.1%
SHW is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 250.0% 10Y total return vs BCPC's 160.5%
- 1.0% yield, 37-year raise streak, vs FMC's 17.0%
- 10.0% ROA vs FMC's -23.0%, ROIC 16.5% vs -21.2%
FMC is the clearest fit if your priority is value.
- Lower P/E (7.7x vs 27.3x)
AVNT is the clearest fit if your priority is income & stability.
- Dividend streak 14 yrs, beta 1.19, yield 2.9%
BCPC carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- Lower volatility, beta 0.33, Low D/E 15.3%, current ratio 2.07x
- PEG 2.41 vs SHW's 3.94
- Beta 0.33, yield 0.5%, current ratio 2.07x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.8% revenue growth vs FMC's -18.3% | |
| Value | Lower P/E (7.7x vs 27.3x) | |
| Quality / Margins | 15.0% margin vs FMC's -72.9% | |
| Stability / Safety | Beta 0.33 vs FMC's 1.63, lower leverage | |
| Dividends | 1.0% yield, 37-year raise streak, vs FMC's 17.0% | |
| Momentum (1Y) | +8.5% vs FMC's -57.1% | |
| Efficiency (ROA) | 10.0% ROA vs FMC's -23.0%, ROIC 16.5% vs -21.2% |
IFF vs SHW vs FMC vs AVNT vs BCPC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IFF vs SHW vs FMC vs AVNT vs BCPC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BCPC leads in 2 of 6 categories
FMC leads 1 • SHW leads 1 • IFF leads 0 • AVNT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BCPC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SHW is the larger business by revenue, generating $23.9B annually — 22.6x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to FMC's -72.9%. On growth, BCPC holds the edge at +8.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $10.8B | $23.9B | $3.4B | $3.3B | $1.1B |
| EBITDAEarnings before interest/tax | $1.7B | $4.5B | -$1.9B | $445M | $267M |
| Net IncomeAfter-tax profit | $839M | $2.6B | -$2.5B | $158M | $158M |
| Free Cash FlowCash after capex | $400M | $2.9B | -$91M | $205M | $182M |
| Gross MarginGross profit ÷ Revenue | +35.1% | +49.1% | +35.3% | +31.7% | +36.3% |
| Operating MarginEBIT ÷ Revenue | +8.0% | +16.1% | -59.5% | +9.3% | +21.0% |
| Net MarginNet income ÷ Revenue | +7.8% | +10.9% | -72.9% | +4.8% | +15.0% |
| FCF MarginFCF ÷ Revenue | +3.7% | +12.1% | -2.7% | +6.3% | +17.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.6% | +6.8% | -4.1% | +2.5% | +8.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +116.6% | +7.5% | -17.8% | +3.8% | +10.6% |
Valuation Metrics
FMC leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 31.2x trailing earnings, SHW trades at a 24% valuation discount to AVNT's 41.0x P/E. Adjusting for growth (PEG ratio), BCPC offers better value at 2.62x vs SHW's 4.51x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $20.0B | $79.0B | $1.7B | $3.3B | $5.1B |
| Enterprise ValueMkt cap + debt − cash | $26.1B | $93.3B | $5.3B | $4.8B | $5.2B |
| Trailing P/EPrice ÷ TTM EPS | -53.60x | 31.18x | -0.77x | 41.01x | 33.58x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.84x | 27.27x | 7.74x | 11.95x | 30.87x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.51x | — | — | 2.62x |
| EV / EBITDAEnterprise value multiple | 13.28x | 21.24x | — | 12.22x | 19.83x |
| Price / SalesMarket cap ÷ Revenue | 1.84x | 3.35x | 0.49x | 1.03x | 4.92x |
| Price / BookPrice ÷ Book value/share | 1.41x | 17.33x | 0.82x | 1.40x | 4.14x |
| Price / FCFMarket cap ÷ FCF | 78.09x | 29.76x | — | 17.16x | 29.51x |
Profitability & Efficiency
BCPC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SHW delivers a 58.2% return on equity — every $100 of shareholder capital generates $58 in annual profit, vs $-82 for FMC. BCPC carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to SHW's 3.16x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs FMC's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.9% | +58.2% | -82.3% | +6.6% | +12.4% |
| ROA (TTM)Return on assets | +3.3% | +10.0% | -23.0% | +2.6% | +9.4% |
| ROICReturn on invested capital | +3.5% | +16.5% | -21.2% | +3.9% | +12.2% |
| ROCEReturn on capital employed | +4.4% | +21.3% | -25.9% | +4.0% | +14.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 2 | 5 | 9 |
| Debt / EquityFinancial leverage | 0.47x | 3.16x | 2.00x | 0.81x | 0.15x |
| Net DebtTotal debt minus cash | $6.1B | $14.3B | $3.6B | $1.4B | $117M |
| Cash & Equiv.Liquid assets | $590M | $207M | $585M | $511M | $75M |
| Total DebtShort + long-term debt | $6.7B | $14.5B | $4.2B | $1.9B | $192M |
| Interest CoverageEBIT ÷ Interest expense | 5.26x | 7.83x | -0.24x | 3.61x | 15.23x |
Total Returns (Dividends Reinvested)
SHW leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BCPC five years ago would be worth $12,424 today (with dividends reinvested), compared to $1,983 for FMC. Over the past 12 months, IFF leads with a +8.5% total return vs FMC's -57.1%. The 3-year compound annual growth rate (CAGR) favors SHW at 12.5% vs FMC's -44.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.6% | -2.1% | -4.0% | +16.0% | +3.6% |
| 1-Year ReturnPast 12 months | +8.5% | -8.0% | -57.1% | +4.1% | -2.2% |
| 3-Year ReturnCumulative with dividends | -13.2% | +42.4% | -82.5% | +2.3% | +26.6% |
| 5-Year ReturnCumulative with dividends | -38.1% | +16.1% | -80.2% | -22.7% | +24.2% |
| 10-Year ReturnCumulative with dividends | -12.6% | +250.0% | -26.8% | +27.8% | +160.5% |
| CAGR (3Y)Annualised 3-year return | -4.6% | +12.5% | -44.0% | +0.8% | +8.2% |
Risk & Volatility
Evenly matched — IFF and BCPC each lead in 1 of 2 comparable metrics.
Risk & Volatility
BCPC is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than FMC's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IFF currently trades 93.0% from its 52-week high vs FMC's 30.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.68x | 0.79x | 1.63x | 1.19x | 0.33x |
| 52-Week HighHighest price in past year | $84.19 | $379.65 | $44.78 | $44.85 | $183.90 |
| 52-Week LowLowest price in past year | $59.14 | $301.58 | $12.17 | $27.48 | $139.17 |
| % of 52W HighCurrent price vs 52-week peak | +93.0% | +84.3% | +30.5% | +81.4% | +86.7% |
| RSI (14)Momentum oscillator 0–100 | 72.5 | 47.6 | 43.4 | 55.2 | 32.9 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 1.6M | 3.2M | 620K | 190K |
Analyst Outlook
Evenly matched — SHW and FMC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IFF as "Buy", SHW as "Buy", FMC as "Hold", AVNT as "Buy", BCPC as "Buy". Consensus price targets imply 32.6% upside for AVNT (target: $48) vs 1.6% for BCPC (target: $162). For income investors, FMC offers the higher dividend yield at 17.01% vs BCPC's 0.54%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $87.75 | $389.43 | $15.58 | $48.40 | $162.00 |
| # AnalystsCovering analysts | 33 | 38 | 42 | 20 | 10 |
| Dividend YieldAnnual dividend ÷ price | +2.0% | +1.0% | +17.0% | +2.9% | +0.5% |
| Dividend StreakConsecutive years of raises | 0 | 37 | 7 | 14 | 11 |
| Dividend / ShareAnnual DPS | $1.60 | $3.17 | $2.33 | $1.08 | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | 0.0% | +0.1% | +0.1% | +2.1% |
BCPC leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FMC leads in 1 (Valuation Metrics). 2 tied.
IFF vs SHW vs FMC vs AVNT vs BCPC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IFF or SHW or FMC or AVNT or BCPC a better buy right now?
For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.
8% revenue growth year-over-year, versus -18. 3% for FMC Corporation (FMC). The Sherwin-Williams Company (SHW) offers the better valuation at 31. 2x trailing P/E (27. 3x forward), making it the more compelling value choice. Analysts rate International Flavors & Fragrances Inc. (IFF) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IFF or SHW or FMC or AVNT or BCPC?
On trailing P/E, The Sherwin-Williams Company (SHW) is the cheapest at 31.
2x versus Avient Corporation at 41. 0x. On forward P/E, FMC Corporation is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Balchem Corporation wins at 2. 41x versus The Sherwin-Williams Company's 3. 94x.
03Which is the better long-term investment — IFF or SHW or FMC or AVNT or BCPC?
Over the past 5 years, Balchem Corporation (BCPC) delivered a total return of +24.
2%, compared to -80. 2% for FMC Corporation (FMC). Over 10 years, the gap is even starker: SHW returned +250. 0% versus FMC's -26. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IFF or SHW or FMC or AVNT or BCPC?
By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.
33β versus FMC Corporation's 1. 63β — meaning FMC is approximately 393% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Balchem Corporation (BCPC) carries a lower debt/equity ratio of 15% versus 3% for The Sherwin-Williams Company — giving it more financial flexibility in a downturn.
05Which is growing faster — IFF or SHW or FMC or AVNT or BCPC?
By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.
8% versus -18. 3% for FMC Corporation (FMC). On earnings-per-share growth, the picture is similar: Balchem Corporation grew EPS 20. 9% year-over-year, compared to -757. 4% for FMC Corporation. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IFF or SHW or FMC or AVNT or BCPC?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus -64. 6% for FMC Corporation — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus -54. 4% for FMC. At the gross margin level — before operating expenses — SHW leads at 48. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IFF or SHW or FMC or AVNT or BCPC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Balchem Corporation (BCPC) is the more undervalued stock at a PEG of 2. 41x versus The Sherwin-Williams Company's 3. 94x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, FMC Corporation (FMC) trades at 7. 7x forward P/E versus 30. 9x for Balchem Corporation — 23. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVNT: 32. 6% to $48. 40.
08Which pays a better dividend — IFF or SHW or FMC or AVNT or BCPC?
All stocks in this comparison pay dividends.
FMC Corporation (FMC) offers the highest yield at 17. 0%, versus 0. 5% for Balchem Corporation (BCPC).
09Is IFF or SHW or FMC or AVNT or BCPC better for a retirement portfolio?
For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
33), 0. 5% yield, +160. 5% 10Y return). FMC Corporation (FMC) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BCPC: +160. 5%, FMC: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IFF and SHW and FMC and AVNT and BCPC?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IFF is a mid-cap quality compounder stock; SHW is a mid-cap quality compounder stock; FMC is a small-cap income-oriented stock; AVNT is a small-cap quality compounder stock; BCPC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.